glutathione mutations in sclc patients Frontiers Frontiers | Targeting lung cancer:
Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death Glutathione Dependent Pathways in Cancer Cells RETRACTED ARTICLE: Novel prognostic biomarkers in small cell lung cancer reveal mutational signatures, genomic mutations, and immune implications Scientific Reports Frontiers Therapeutic Potential of Glutamine Pathway in Lung Cancer Unveiling the powerhouse: ASCL1 driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation Cancer & Metabolism Springer Nature Link Oncology Reports
Pay in 4 interest-free payments of $7.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





